NCT00058006 Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00057850 BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00057785 Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer Status COMPLETED Phase PHASE2
NCT00056004 Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Status COMPLETED Phase PHASE2
NCT00054977 Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00054561 Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00054054 S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00052611 Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia Status COMPLETED Phase PHASE2
NCT00052429 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00049140 EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00047008 Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00045669 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Status COMPLETED Phase PHASE2
NCT00042926 Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer Status COMPLETED Phase NA
NCT00041171 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Status WITHDRAWN Phase PHASE3
NCT00040911 Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma Status COMPLETED Phase NA
NCT00040807 Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00036881 Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00036790 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00030576 Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2